Post Categories
Let’s Talk Neuro at the AAIC 2016 in Toronto, Canada, July 24-27, 2016
July 19, 2016
Join us from July 24-27, 2016 in Toronto, Canada for the Alzheimer’s Association International Conference. QPS neuroscientists will attend the AAIC 2016 and would…
QPS Netherlands scientist Daniel Wilffert nominated for New Investigator Award by Bioanalysis Zone!
June 22, 2016
Since 2012, a New Investigator Award has been given annually to honor excellence among bioanalytical scientists within their first five years in the industry….
We are exhibiting at the DIA 2016 Annual Meeting at our booth #1200 between June 26-30 at Philadelphia, PA, USA.
June 21, 2016
We are exhibiting at the DIA 2016 Annual Meeting at our booth #1200 between June 26-30 at Philadelphia, PA, USA. If you are attending…
Ben Chien is an EY Entrepreneur Of The Year® 2016 Finalist for Greater Philadelphia!
May 17, 2016
QPS CEO Ben Chien has made it through to the round of 30 (31, actually) being considered for this year’s prestigious EY Entrepreneur Of…
Another CRO Leadership Award! For Compatibility, Expertise, Quality and Reliability
May 17, 2016
Each year, Life Science Leader honors CROs that are the top performers in Compatibility, Capabilities, Expertise, Quality, and Reliability. To determine the winners, the…
QPS’ Patient Recruitment Management at the 2016 Annual Meeting of the Clinical Trials Community in Israel
May 4, 2016
Patient recruitment is one of the most critical foundations of any clinical trial. Effective patient recruitment sets the trial down a path toward success…
QPS Global Clinical Operations Team Aces Enrollment for a Global Study of a Prostate Cancer Drug
April 19, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of an investigational…
SCIEX and QPS Join Forces to Bring You a New Bioanalysis Solution for Biologics
April 5, 2016
Over the past 10 years, large molecule therapies have increased from 10% to nearly 50% of the typical pharma and biopharmaceutical pipeline. This transition…
QPS Now Has Exclusive Distribution Rights for Samsara’s Specialized Human Liver Cells
March 25, 2016
QPS and Samsara Sciences have solidified a cell supply partnership for the production, characterization and distribution of primary human liver cells including hepatocytes and…
QPS will have a strong presence at ASCPT 2016 in San Diego March 9th-11th
March 9, 2016
QPS will have a strong presence at ASCPT 2016 in San Diego March 9th-11th. Several members of QPS’ Early Phase Clinical team will be…
QPS is proud to announce that our toxicology facility passed a GLP audit by the US FDA in 3Q 2015 with no major findings.
March 7, 2016
We are exhibiting at SOT 55th Annual Meeting and ToxExpoTM. Please visit our booth (#1813) between March 13-16 at the New Orleans Convention Center,…
QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe!
March 2, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of a newly…
Attacking KRAS Proteins to Kill Cancer
December 14, 2022
Recent advancements have led to the development of new cancer therapies that target mutations in KRAS proteins, which were once considered untreatable. In 2021,…
Offering Pain Relief Without Opioids, Vertex’s Sodium Channel Blocker Advances
December 12, 2022
Opioid pain relievers are highly addictive, contributing to high rates of opioid use disorder and overdose. According to the World Health Organization, opioid use…
Children with Retinitis Pigmentosa to See the World
December 7, 2022
Retinitis pigmentosa is a degenerative eye condition that slowly destroys the retina, the light-sensitive tissue at the back of the eye. For Canadian couple…
Reporting Live From the Brain — Tiny Microscope Tracks Activity in Moving Mice
December 5, 2022
Human brains consist of around 86 billion neurons that connect and communicate with each other, forming an intricate network. Understanding how the human brain…
From Cultural Rite to Clinical Trial — Examining the Therapeutic Potential of Mescaline
November 28, 2022
Psychedelics are having a moment, as researchers, startups, and regulators are recognizing the potential of these previously stigmatized compounds for treating mental health disorders….
Researchers Find New Hybrid Virus in Lung Cells
November 21, 2022
Winter is approaching, and with it, flu season. Cases of both influenza (flu) and the respiratory syncytial virus (RSV) tend to experience their peak…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…